SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-243053
Filing Date
2023-09-27
Accepted
2023-09-27 07:30:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D d519002dsc13d.htm SC 13D 66603
2 EX-3 d519002dex993.htm EX-99.3 35911
3 EX-4 d519002dex994.htm EX-99.4 8852
  Complete submission text file 0001193125-23-243053.txt   113104
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Subject) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94162 | Film No.: 231281818
SIC: 2836 Biological Products, (No Diagnostic Substances)